Related Experiment Video
Updated: Feb 15, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia
Yali Xu1, Joseph P Milazzo2, Tim D D Somerville2
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA; Molecular and Cellular Biology Program, Stony Brook University, New York, NY 11794, USA.
Abstract:
Targeting of general coactivators is an emerging strategy to interfere with oncogenic transcription factors (TFs). However, coactivator perturbations often lead to pleiotropic effects by influencing numerous TFs. Here we identify TAF12, a subunit of TFIID and SAGA coactivator complexes, as a selective requirement for acute myeloid leukemia (AML) progression. We trace this dependency to a direct interaction between the TAF12/TAF4 histone-fold heterodimer and the transactivation domain of MYB, a TF with established roles in leukemogenesis. Ectopic expression of the TAF4 histone-fold fragment can efficiently squelch TAF12 in cells, suppress MYB, and regress AML in mice. Our study reveals a strategy for potent MYB inhibition in AML and highlights how an oncogenic TF can be selectively neutralized by targeting a general coactivator complex.
Insights
Researchers found TAF12 is crucial for acute myeloid leukemia (AML) progression by interacting with the MYB transcription factor. Targeting this interaction offers a new strategy for AML treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Targeting general coactivators is a strategy to inhibit oncogenic transcription factors (TFs).
- Coactivator perturbations can cause broad effects impacting multiple TFs.
- Acute myeloid leukemia (AML) is driven by aberrant TF activity.
Purpose of the Study:
- Identify specific coactivator requirements in AML.
- Investigate the role of TAF12 in leukemogenesis.
- Develop a targeted approach for AML therapy.
Main Methods:
- Identified TAF12 as essential for AML progression.
- Characterized the interaction between TAF12/TAF4 and MYB.
- Utilized TAF4 histone-fold fragment to inhibit TAF12 function.
- Tested efficacy in mouse models of AML.
Main Results:
- TAF12, a subunit of TFIID and SAGA, is selectively required for AML.
- A direct interaction exists between the TAF12/TAF4 heterodimer and MYB's transactivation domain.
- Ectopic expression of TAF4 fragment suppressed MYB and led to AML regression in mice.
Conclusions:
- TAF12 is a key coactivator for the oncogenic TF MYB in AML.
- Targeting the TAF12-MYB interaction provides a selective strategy for AML treatment.
- This approach offers a way to neutralize oncogenic TFs by targeting general coactivator complexes.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pyelonephritis I: Introduction
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...